Meghan V. Joyce
Director · Guardant Health, Inc.
- 2024
- Jun 22, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Meghan V. Joyce files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- Terilyn J. Monroe - $14.82M in GH purchases and sales in the last 12 months
- Chris Freeman - $13.68M in GH purchases and sales in the last 12 months
- Helmy Eltoukhy - $12.63M in GH purchases and sales in the last 12 months
- Kumud Kalia - $5.78M in GH purchases and sales in the last 12 months
- John G. Saia - $4.25M in GH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Meghan V. Joyce?
Meghan V. Joyce is a corporate insider, tracked as Director of Guardant Health, Inc. (GH). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Meghan V. Joyce last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 11 filings going back to 2024.
Has Meghan V. Joyce been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.37M) across all tracked filings.
